Moderna Announces FDA's Breakthrough Designation For MRNA-1345; Plans License Application In H1
30/1 13:49
(RTTNews) - Moderna, Inc. (MRNA) announced mRNA-1345 has been granted Breakthrough Therapy Designation by the FDA for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 years or older. The designation was based on positive topline data from the Con...